Pharmafile Logo

Glaucoma in perspective

Wilmington Healthcare launches new, integrated, digital channel to help pharma engage with the NHS

Healthcare intelligence provider Wilmington Healthcare has integrated its tools and resources online to help pharma navigate changes within the NHS, following the official launch of Sustainability and Transformation Plans (STPs)....

Wilmington Healthcare

Flex Pharma appoints new R&D president

William McVicar joins from Inotek

- PMLiVE

Nitro Digital expands EMEA management team

And opens offices in Ireland, Italy and Pakistan

- PMLiVE

Incisive Health appoints new director

Jean-Louis Roux joins the firm from EURORDIS

- PMLiVE

Dominic Moorhead joins Ferring Pharmaceuticals

He takes up executive VP and chief financial officer role

- PMLiVE

AbbVie and J&J file first non-cancer use for Imbruvica with FDA

Seeks FDA approval to treat GVHD patients

- PMLiVE

BMS closes in on colorectal cancer indication for Opdivo

Gains US priority review to treat patients with dMMR or MSI-H colorectal cancer

- PMLiVE

Behaviour Change

Investigating the science behind behaviour change

- PMLiVE

Lucid Partners US changes its name to Lighthouse Medical Communications US

With immediate effect Lucid Partners US will change its name to Lighthouse Medical Communications US.The demand for the Lucid Group services in the US has grown rapidly, and by creating a...

Lucid Group Communications Limited

- PMLiVE

FDA approves Teva’s Huntington’s disease drug at second attempt

Austedo will treat fatal degenerative disorder chorea

- PMLiVE

Astellas agrees €800m deal to buy Belgian biotech Ogeda

Will pay another €300m if fezolinetant meets clinical and regulatory targets

- PMLiVE

John LaMattina joins Frequency Therapeutics in advisory role

The ex-Pfizer R&D head will sit on its Scientific Advisory Board

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links